Hawken Miller joined the "First Opinion Podcast" this week to discuss how Sarept...
Pharmaceutical companies, governments, and the global health care community must...
At a Senate subcommittee hearing Tuesday, members discussed reforms that might a...
Takeda announced that it has voluntarily withdrawn its application to the FDA fo...
A new report resurfaces a thorny challenge in researchers’ quest to turn DNA int...
Digital health funding remained low in the first half of the year as the industr...
Express Scripts will add three biosimilar versions of AbbVie's blockbuster arthr...
Japanese drugmaker Eisai said Tuesday that Ivan Cheung, chairman of its U.S. ope...
Xylazine, which is commonly known as “tranq,” has helped to accelerate the alrea...
We need a more precise, scientific, and shared understanding of just what recove...
“It was very much about following the algorithms and basically not using your cl...
Congress must reauthorize the essential PAHPA framework and enact a disciplined ...
NIH research fellows want to unionize, in large part because they want a raise. ...
The University of Texas at Arlington received an Award of Excellence for Innovat...
“Our data demonstrate that cetuximab plus radiotherapy represents an active trea...
In a new study, researchers and members of the Muwekma Ohlone Tribe of the San F...
